Get started
Author

Amirsalar Mansouri

ORCID: 0000-0001-9014-5024
Observed ORCID: 0000-0001-9014-5024
OpenAlex ID: A5102633862
Mass spectrometry imaging tutorial: From cancer biomarker discovery to clinical applications
2025 · Amirsalar Mansouri, Nipun Babu Varukattu, et al. · Analytica Chimica Acta · 4
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al. · Cancer Immunology Research · 2
Proteomic Analysis of Chronic Binge Alcohol-Induced Hippocampal and Anterior Cingulate Cortex Neuroadaptations in Simian Immunodeficiency Virus (SIV)-Infected Female Rhesus Macaques
2025 · Taylor Fitzpatrick-Schmidt, Amirsalar Mansouri, et al. · Journal of Neuroimmune Pharmacology · 1
PDF
Abstract A004: Stromal-targeting payloads are not functionally equivalent in pancreatic cancer: Decorin-armed VSV couples matrix remodeling with systemic immune reprogramming
2026 · Sina Aslanabadi, Garima Sinha, et al. · Cancer Research
Integrative Proteomic Analysis Reveals VMG Oncolytic Virus–Induced Molecular Reprogramming in Pancreatic Ductal Adenocarcinoma
2026 · Omeed Moaven, Sina Aslanabadi, et al. · Research Square
PDF
Supplementary Figure 13 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Table 1 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 14 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 1 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 5 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 4 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 12 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 8 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 3 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 2 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Table 3 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 9 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 10 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 11 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 6 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Table 4 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Data from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Figure 7 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Supplementary Table 2 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
2026 · Phaethon Philbrook, Matthew J. Dean, et al.
Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer
2026 · Amirsalar Mansouri, Olivia Hart, et al. · Cells
PDF
Works count: 30
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type